Skip to main content
Top
Published in: Critical Care 1/2011

Open Access 01-02-2011 | Poster presentation

Dexmedetomidine improves attention and recall in agitated critically ill patients

Authors: MM Mirski, RG Gill, PM Murakami, CT Thompson, JL Lewin

Published in: Critical Care | Special Issue 1/2011

Login to get access

Excerpt

It is of clinical interest to maintain patient comfort in the ICU and yet preserve their intellectual function, arousal and interaction. Recently, dexmedetomidine (DEX) was demonstrated in the ANIST Trial to preserve intellectual function as compared with propofol (PRO) when used as conscious sedation in both agitated neurologically intact and brain-injured critically ill patients [1]. The purpose of this study was to further understand whether selective areas of cognition were specifically affected by PRO and DEX through sub-analysis of the Trial's results on each of the five subscales of the Adapted Cognitive Exam (ACE). …
Literature
1.
go back to reference Mirski MA, Lewin JJ, Ledroux S, et al.: Cognitive improvement during continuous sedation in critically ill, awake and responsive patients: the Acute Neurological ICU Sedation Trial (ANIST). Intensive Care Med 2010, 36: 1505-1513. 10.1007/s00134-010-1874-9CrossRefPubMed Mirski MA, Lewin JJ, Ledroux S, et al.: Cognitive improvement during continuous sedation in critically ill, awake and responsive patients: the Acute Neurological ICU Sedation Trial (ANIST). Intensive Care Med 2010, 36: 1505-1513. 10.1007/s00134-010-1874-9CrossRefPubMed
Metadata
Title
Dexmedetomidine improves attention and recall in agitated critically ill patients
Authors
MM Mirski
RG Gill
PM Murakami
CT Thompson
JL Lewin
Publication date
01-02-2011
Publisher
BioMed Central
Published in
Critical Care / Issue Special Issue 1/2011
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9775

Other articles of this Special Issue 1/2011

Critical Care 1/2011 Go to the issue